chebulinic acid has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angayarkanni, N; Shanmuganathan, S | 1 |
| Basu, S; Chakroborty, D; Liu, Z; Lu, K; Lu, T; Sarkar, C; Xie, Z | 1 |
2 other study(ies) available for chebulinic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Chebulagic acid and Chebulinic acid inhibit TGF-β1 induced fibrotic changes in the chorio-retinal endothelial cells by inhibiting ERK phosphorylation.
Topics: Animals; Benzopyrans; Binding Sites; Cell Movement; Cell Proliferation; Cells, Cultured; Choroid; Diabetic Retinopathy; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Glucosides; Hydrolyzable Tannins; Macaca mulatta; Molecular Docking Simulation; Neovascularization, Pathologic; Phosphorylation; Plant Extracts; Protein Binding; Receptors, Transforming Growth Factor beta; Retinal Vessels; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hydrolyzable Tannins; Male; Mice; Neovascularization, Pathologic; Phosphorylation; Plant Extracts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2012 |